These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28334234)

  • 1. Breast cancer risk-associated variants at 6q25.1 influence risk of hepatocellular carcinoma in a Chinese population.
    Li J; Wang Y; Zhu Y; Gong Y; Yang Y; Tian J; Zhang Y; Zou D; Peng X; Ke J; Gong J; Zhong R; Chang J
    Carcinogenesis; 2017 Apr; 38(4):447-454. PubMed ID: 28334234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.
    Long J; Cai Q; Sung H; Shi J; Zhang B; Choi JY; Wen W; Delahanty RJ; Lu W; Gao YT; Shen H; Park SK; Chen K; Shen CY; Ren Z; Haiman CA; Matsuo K; Kim MK; Khoo US; Iwasaki M; Zheng Y; Xiang YB; Gu K; Rothman N; Wang W; Hu Z; Liu Y; Yoo KY; Noh DY; Han BG; Lee MH; Zheng H; Zhang L; Wu PE; Shieh YL; Chan SY; Wang S; Xie X; Kim SW; Henderson BE; Le Marchand L; Ito H; Kasuga Y; Ahn SH; Kang HS; Chan KY; Iwata H; Tsugane S; Li C; Shu XO; Kang DH; Zheng W
    PLoS Genet; 2012; 8(2):e1002532. PubMed ID: 22383897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population.
    Wang Y; He Y; Qin Z; Jiang Y; Jin G; Ma H; Dai J; Chen J; Hu Z; Guan X; Shen H
    Breast Cancer Res; 2014 Aug; 16(4):422. PubMed ID: 25116933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Nucleotide Polymorphisms in
    Bei C; Liu S; Yu X; Qiu M; Tang B; Liao W; He S; Yu H
    Biomed Res Int; 2018; 2018():1540201. PubMed ID: 30662901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese population.
    Han J; Jiang T; Bai H; Gu H; Dong J; Ma H; Hu Z; Shen H
    Breast Cancer Res Treat; 2011 Oct; 129(3):901-7. PubMed ID: 21528353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematical analyses of variants in DNase I hypersensitive sites to identify hepatocellular carcinoma susceptibility loci in a Chinese population.
    Jiang T; Du F; Qin N; Lu Q; Dai J; Shen H; Hu Z
    J Gastroenterol Hepatol; 2017 Nov; 32(11):1887-1894. PubMed ID: 28321907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of potential regulatory function of breast cancer risk locus at 6q25.1.
    Sun Y; Ye C; Guo X; Wen W; Long J; Gao YT; Shu XO; Zheng W; Cai Q
    Carcinogenesis; 2016 Feb; 37(2):163-168. PubMed ID: 26645718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.
    Barzan D; Veldwijk MR; Herskind C; Li Y; Zhang B; Sperk E; Du WD; Zhang XJ; Wenz F
    Eur J Hum Genet; 2013 Nov; 21(11):1286-92. PubMed ID: 23486537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Functional Genetic Variants of HOTAIR with Hepatocellular Carcinoma (HCC) Susceptibility in a Chinese Population.
    Li H; Tang XM; Liu Y; Li W; Chen Q; Pan Y
    Cell Physiol Biochem; 2017; 44(2):447-454. PubMed ID: 29141248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new discovery of STAT4 single nucleotide polymorphisms associated with hepatocellular carcinoma risk in Chinese Han population: a case-control study.
    Chao X; Wu J; Zhang W; Feng X; Zhao L; Huang F; Jiang C
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein genetic polymorphisms increase susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
    Peng Q; Ren S; Lao X; Lu Y; Zhang X; Chen Z; Qin X; Li S
    Tumour Biol; 2014 Oct; 35(10):10169-76. PubMed ID: 25027406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).
    Hein R; Maranian M; Hopper JL; Kapuscinski MK; Southey MC; Park DJ; Schmidt MK; Broeks A; Hogervorst FB; Bueno-de-Mesquita HB; Muir KR; Lophatananon A; Rattanamongkongul S; Puttawibul P; Fasching PA; Hein A; Ekici AB; Beckmann MW; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Sawyer E; Tomlinson I; Kerin M; Miller N; Marmee F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Cordina-Duverger E; Menegaux F; Truong T; Bojesen SE; Nordestgaard BG; Flyger H; Milne RL; Perez JI; Zamora MP; Benítez J; Anton-Culver H; Ziogas A; Bernstein L; Clarke CA; Brenner H; Müller H; Arndt V; Stegmaier C; Rahman N; Seal S; Turnbull C; Renwick A; Meindl A; Schott S; Bartram CR; Schmutzler RK; Brauch H; Hamann U; Ko YD; ; Wang-Gohrke S; Dörk T; Schürmann P; Karstens JH; Hillemanns P; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Bogdanova NV; Zalutsky IV; Antonenkova NN; Bermisheva M; Prokovieva D; Farahtdinova A; Khusnutdinova E; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen J; Chen X; Beesley J; ; ; Lambrechts D; Zhao H; Neven P; Wildiers H; Nickels S; Flesch-Janys D; Radice P; Peterlongo P; Manoukian S; Barile M; Couch FJ; Olson JE; Wang X; Fredericksen Z; Giles GG; Baglietto L; McLean CA; Severi G; Offit K; Robson M; Gaudet MM; Vijai J; Alnæs GG; Kristensen V; Børresen-Dale AL; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Figueroa JD; García-Closas M; Lissowska J; Sherman ME; Hooning M; Martens JW; Seynaeve C; Collée M; Hall P; Humpreys K; Czene K; Liu J; Cox A; Brock IW; Cross SS; Reed MW; Ahmed S; Ghoussaini M; Pharoah PD; Kang D; Yoo KY; Noh DY; Jakubowska A; Jaworska K; Durda K; Złowocka E; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Shen CY; Yu JC; Hsu HM; Hou MF; Orr N; Schoemaker M; Ashworth A; Swerdlow A; Trentham-Dietz A; Newcomb PA; Titus L; Egan KM; Chenevix-Trench G; Antoniou AC; Humphreys MK; Morrison J; Chang-Claude J; Easton DF; Dunning AM
    PLoS One; 2012; 7(8):e42380. PubMed ID: 22879957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CASP 3 genetic polymorphisms and risk of Hepatocellular carcinoma: a case-control study in a Chinese population.
    Deng B; Liu F; Luo L; Wei Y; Li B; Yang H
    Tumour Biol; 2016 Jul; 37(7):8985-91. PubMed ID: 26758428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two polymorphisms of USF1 gene (-202G>A and -844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case-control study in Chinese Han population.
    Zhou X; Zhu HQ; Ma CQ; Li HG; Liu FF; Chang H; Lu J
    Med Oncol; 2014 Dec; 31(12):301. PubMed ID: 25367853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population.
    Bi J; Zhong C; Li K; Chu H; Wang B
    Biomed Res Int; 2013; 2013():138785. PubMed ID: 23984316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of twelve polymorphisms in three onco-lncRNA genes with hepatocellular cancer risk and prognosis: A case-control study.
    Wang BG; Xu Q; Lv Z; Fang XX; Ding HX; Wen J; Yuan Y
    World J Gastroenterol; 2018 Jun; 24(23):2482-2490. PubMed ID: 29930469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1.
    Zheng W; Long J; Gao YT; Li C; Zheng Y; Xiang YB; Wen W; Levy S; Deming SL; Haines JL; Gu K; Fair AM; Cai Q; Lu W; Shu XO
    Nat Genet; 2009 Mar; 41(3):324-8. PubMed ID: 19219042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas.
    Fejerman L; Chen GK; Eng C; Huntsman S; Hu D; Williams A; Pasaniuc B; John EM; Via M; Gignoux C; Ingles S; Monroe KR; Kolonel LN; Torres-Mejía G; Pérez-Stable EJ; Burchard EG; Henderson BE; Haiman CA; Ziv E
    Hum Mol Genet; 2012 Apr; 21(8):1907-17. PubMed ID: 22228098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between methylenetetrahydrofolate reductase tagging polymorphisms and susceptibility of hepatocellular carcinoma: a case-control study.
    Zhang S; Lin J; Jiang J; Chen Y; Tang W; Liu L
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31694048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression quantitative trait loci for TNFRSF10 influence both HBV infection and hepatocellular carcinoma development.
    Wen J; Song C; Liu J; Chen J; Zhai X; Hu Z
    J Med Virol; 2016 Mar; 88(3):474-80. PubMed ID: 26297860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.